D. Sharma
Vorstandsvorsitzender bei Silq Technologies Corp.
Profil
D.
Verne Sharma is currently the Chief Executive Officer & Director at Silq Technologies Corp., the Director at Biovision AG, and the Director at Black Light Surgical, Inc. Previously, he served as the Chairman & Chief Executive Officer at RxSight, Inc. from 2014 to 2015, the President & Chief Executive Officer at Cosmetic Laser Eye & Refractive Centers of America LLC in 2003, the Director at Astora Women's Health, Inc., the President & Chief Operating Officer at Summit Technology, Inc. from 1996 to 2000, and the Vice President-Business Development at Southeast Fuels, Inc. from 2005 to 2007.
He also has experience as a Principal at DVS Consulting LLC.
Aktive Positionen von D. Sharma
| Unternehmen | Position | Beginn |
|---|---|---|
| Biovision AG | Direktor/Vorstandsmitglied | - |
Black Light Surgical, Inc.
 Black Light Surgical, Inc. Packaged SoftwareTechnology Services Black Light Surgical, Inc. has developed breakthrough technology to revolutionize medical imaging, based on years of research at Cedars-Sinai Medical Center. The company is based in Sunny Isles Beach, FL. The technology incorporates principles of auto-fluorescence lifetime and time-resolved auto-fluorescence spectroscopy, which can be used intra-operatively and is highly accurate in characterizing tissue without the need for dyes or drugs. The company's initial focus is on addressing the long-standing problem of breast cancer, where one-third of patients require a second or third procedure following breast conserving surgery (BCS) to fully remove the cancer. | Direktor/Vorstandsmitglied | - |
| Silq Technologies Corp. | Vorstandsvorsitzender | 01.06.2020 |
Ehemalige bekannte Positionen von D. Sharma
| Unternehmen | Position | Ende |
|---|---|---|
| RXSIGHT, INC. | Vorstandsvorsitzender | 01.01.2015 |
Southeast Fuels, Inc.
 Southeast Fuels, Inc. Engineering & ConstructionIndustrial Services Southeast Fuels, Inc. markets industrial and utility coal. It supports industrial and utility users of fuel combustion products such as coal, fuel oil and natural gas. The company was founded by Ralph K. Shelton on November 3, 1984 and is headquartered in Greensboro, NC. | Corporate Officer/Principal | 01.12.2007 |
| Cosmetic Laser Eye & Refractive Centers of America LLC | Präsident | 01.01.2003 |
| Summit Technology, Inc. | Präsident | 01.01.2000 |
| DVS Consulting LLC | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| RXSIGHT, INC. | Electronic Technology |
| Private Unternehmen | 8 |
|---|---|
Astora Women's Health, Inc.
 Astora Women's Health, Inc. Medical SpecialtiesHealth Technology Astora Women's Health, Inc. engages in the provision of pelvic health solutions. The company was founded by Dr. Brantley Scott in 1972 and is headquartered in Minnetonka, MN. | Health Technology |
| Summit Technology, Inc. | Health Technology |
Southeast Fuels, Inc.
Southeast Fuels, Inc. Engineering & ConstructionIndustrial Services Southeast Fuels, Inc. markets industrial and utility coal. It supports industrial and utility users of fuel combustion products such as coal, fuel oil and natural gas. The company was founded by Ralph K. Shelton on November 3, 1984 and is headquartered in Greensboro, NC. | Industrial Services |
| DVS Consulting LLC | |
| Biovision AG | |
| Cosmetic Laser Eye & Refractive Centers of America LLC | |
Black Light Surgical, Inc.
Black Light Surgical, Inc. Packaged SoftwareTechnology Services Black Light Surgical, Inc. has developed breakthrough technology to revolutionize medical imaging, based on years of research at Cedars-Sinai Medical Center. The company is based in Sunny Isles Beach, FL. The technology incorporates principles of auto-fluorescence lifetime and time-resolved auto-fluorescence spectroscopy, which can be used intra-operatively and is highly accurate in characterizing tissue without the need for dyes or drugs. The company's initial focus is on addressing the long-standing problem of breast cancer, where one-third of patients require a second or third procedure following breast conserving surgery (BCS) to fully remove the cancer. | Technology Services |
| Silq Technologies Corp. |
